For the Treatment of Cancer
EGFR (Epidermal (skin) Growth Factor
Receptor is found on the surface of some
cells and helps control cell growth by
binding (joining) with certain proteins. It is
found on many normal cells and some
cancer cells. Panitumumab is an EGFR
Inhibitor. It slows (inhibits) the growth of
some cancer cells.
How it is given
We will inject it into a vein over 60 – 90
minutes, every two weeks.
Common Side Effects
ξ Acne-like rash on the face and body
ξ Abdominal distress such as pain,
nausea, vomiting, diarrhea, or
ξ Mouth sores
Rare Side Effects
ξ Allergic reaction
ξ Cough, inflamed lungs
ξ Low magnesium levels in the blood
Call Your Health Care Provider if you
ξ Fever of 100.8° F or greater.
ξ Symptoms of an allergic reaction
o Itching or hives
o New or increased problems
ξ You may need to take medicines
before you receive panitumumab to
help prevent an allergic reaction.
ξ You must use safety measures to
prevent pregnancy for yourself or
any sexual partners during treatment
and for a prescribed amount of time
once treatment has ended.
Your health care team may have given you this information as part of your care. If so, please use it and call if you
have any questions. If this information was not given to you as part of your care, please check with your doctor. This
is not medical advice. This is not to be used for diagnosis or treatment of any medical condition. Because each
person’s health needs are different, you should talk with your doctor or others on your health care team when using
this information. If you have an emergency, please call 911. Copyright © 7/2016 University of Wisconsin Hospitals
and Clinics Authority. All rights reserved. Produced by the Department of Nursing. HF#6738